PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 67 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,671,000 | +21.5% | 650,000 | +18.2% | 0.13% | +4.9% |
Q4 2020 | $1,375,000 | -26.2% | 550,000 | -21.4% | 0.12% | -41.9% |
Q4 2018 | $1,862,000 | -63.2% | 700,000 | -22.6% | 0.21% | -63.9% |
Q3 2018 | $5,066,000 | +18.6% | 904,686 | +7.4% | 0.58% | -1.2% |
Q2 2018 | $4,272,000 | -21.7% | 842,632 | +5.3% | 0.59% | -28.9% |
Q1 2018 | $5,456,000 | -9.7% | 800,000 | 0.0% | 0.83% | +16.8% |
Q4 2017 | $6,040,000 | +4.9% | 800,000 | -20.0% | 0.71% | -13.7% |
Q3 2017 | $5,760,000 | +3.5% | 1,000,000 | -9.1% | 0.82% | -13.1% |
Q2 2017 | $5,566,000 | +114.1% | 1,100,000 | +10.0% | 0.95% | +86.2% |
Q1 2017 | $2,600,000 | +129.3% | 1,000,000 | +23.5% | 0.51% | +77.0% |
Q4 2016 | $1,134,000 | -23.5% | 810,000 | 0.0% | 0.29% | +19.1% |
Q3 2016 | $1,482,000 | +13.7% | 810,000 | 0.0% | 0.24% | -28.9% |
Q2 2016 | $1,304,000 | -15.3% | 810,000 | 0.0% | 0.34% | +1.5% |
Q1 2016 | $1,539,000 | -17.0% | 810,000 | 0.0% | 0.33% | +22.8% |
Q4 2015 | $1,855,000 | +12.6% | 810,000 | -10.0% | 0.27% | +29.5% |
Q3 2015 | $1,647,000 | -50.1% | 900,000 | -25.0% | 0.21% | -35.0% |
Q2 2015 | $3,300,000 | – | 1,200,000 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,360,000 | $6,895,000 | 5.06% |
Omega Fund Management, LLC | 778,230 | $3,946,000 | 2.91% |
BVF INC/IL | 5,346,838 | $27,108,000 | 2.65% |
Virtus ETF Advisers LLC | 152,550 | $773,000 | 0.68% |
SPHERA FUNDS MANAGEMENT LTD. | 842,632 | $4,272,000 | 0.59% |
Tekla Capital Management LLC | 2,087,380 | $10,583,000 | 0.40% |
Schonfeld Strategic Advisors LLC | 828,600 | $4,201,000 | 0.23% |
Orbimed Advisors | 3,140,000 | $15,920,000 | 0.19% |
Lombard Odier Asset Management (USA) Corp | 563,878 | $2,859,000 | 0.19% |
Rhenman & Partners Asset Management AB | 300,000 | $1,521,000 | 0.16% |